Light Chain (AL) Amyloidosis
RareBlood Disorders
Light Chain (AL) Amyloidosis is treated with 1 medication in our database, including Darzalex. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Janssen. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Light Chain (AL) Amyloidosis treatment below.
What help exists for Light Chain (AL) Amyloidosis
2
drugs indexed
2
with copay cards
2
with patient assistance
2
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Light Chain (AL) Amyloidosis
2 totalDarzalex Faspro
daratumumab and hyaluronidase-fihj (human recombinant) · Janssen
🎟💙Darzalex
Daratumumab · Janssen
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Light Chain (AL) Amyloidosis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Grants for Light Chain (AL) Amyloidosis patients
2 total · 2 openLight Chain (AL) Amyloidosis is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →